Novo Nordisk (NVO) Leads Alzheimer’s Prevention Race, But Eli Lilly (LLY) Could Win the Market
Novo Nordisk leads the race for the first Alzheimer’s prevention pill, with insights on clinical progress and what investors should know about this breakthrough.
Read this issue
